↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

832 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   -aminosalicylic acid   Aminosalicylic Acid   D00162   -   -   2件:
96,
97 
 2   0.25 mg rpc1063   -   -   -   -   2件:
96,
97 
 3   0114-0006b   -   -   -   -   2件:
46,
96 
 4   10% metronidazole ointment   Metronidazole   D00409, D05016, D05017   -   -   1件:
96 
 5   1000 iu d3   -   -   -   -   1件:
96 
 6   13-valent pneumococcal conjugated vaccine (pcv13)   -   -   -   -   1件:
96 
 7   1mg rpc1063   -   -   -   -   1件:
96 
 8   2'-fucosyllactose   -   -   -   -   2件:
96,
97 
 9   23-valent polysaccharide pneumococcal vaccine   -   -   -   -   1件:
96 
 10   23-valent polysaccharide pneumococcal vaccine (pneumovax tm)   -   -   -   -   2件:
96,
97 
 11   4-aminosalicylic acid   Aminosalicylic Acid   D00162   -   -   1件:
96 
 12   4-aminosalicylic acid extended release granules   Aminosalicylic Acid   D00162   -   -   1件:
96 
 13   40 mg msb11022   -   -   -   -   4件:
46,
96,
97,
271 
 14   42942019   -   -   -   -   4件:
46,
96,
97,
271 
 15   5-aminosalicylate   5-aminosalicylate   D00377   -   -   2件:
96,
97 
 16   5-aminosalicylate (pentasa, ferring)   5-aminosalicylate, Mesalazine   D00377   -   -   2件:
96,
97 
 17   5-aminosalicylic acid   Mesalazine, Aminosalicylic Acid   D00162, D00377   -   -   2件:
96,
97 
 18   5-asa   Mesalazine   D00377   -   -   2件:
96,
97 
 19   5-asa, prednisone, azathioprine or remicade   Mesalazine, Azathioprine, Ethanol   D00068, D00238, D00377, D02798, D03033, D04855, D06542   -   -   1件:
96 
 20   5-htp   -   -   -   -   2件:
96,
97 
 21   5000 iu d3   -   -   -   -   1件:
96 
 22   549-0261/f02-01   -   -   -   -   2件:
96,
97 
 23   6 mercaptopurine   Mercaptopurine, 6 mercaptopurine   D00161, D04931   1件: HPRT1   1件: Purine metabolism   2件:
96,
97 
 24   6-[(methyl-4-nitro-1h-imidazol-5-yl)thio]-1h-purine   -   -   -   -   1件:
96 
 25   6-mp   Mercaptopurine   D00161, D04931   1件: HPRT1   1件: Purine metabolism   2件:
96,
97 
 26   683699   -   -   -   -   1件:
96 
 27   6mp   Mercaptopurine   D00161, D04931   1件: HPRT1   1件: Purine metabolism   2件:
94,
96 
 28   80 mg dr-6mp   Mercaptopurine   D00161, D04931   1件: HPRT1   1件: Purine metabolism   1件:
96 
 29   99mtc-s-hynic certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   2件:
46,
96 
 30   ?-3 polyunsaturated fatty acid   -   -   -   -   1件:
96 
 31   [14c]-rpc1063 solution (0.1 mg/ml) for oral administration   -   -   -   -   3件:
13,
96,
97 
 32   [18f]fspg   -   -   -   -   2件:
96,
97 
 33   Ab1010   Masitinib   D10229   1件: KIT   2件: MAPK signaling pathway, Pathways in cancer   6件:
2,
5,
6,
13,
46,
96 
 34   Abatacept   Abatacept   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300 
 35   Abbv-066   -   -   -   -   2件:
96,
97 
 36   Abr-215062 sodium salt   -   -   -   -   2件:
13,
96 
 37   Abt-494   -   -   -   -   3件:
46,
96,
97 
 38   Abt-874   -   -   -   -   1件:
96 
 39   Abx464   ABX464   -   -   -   3件:
46,
96,
97 
 40   Accelerated 1 hour-infusion   -   -   -   -   2件:
96,
97 
 41   Accelerated 30 minutes-infusion   -   -   -   -   2件:
96,
97 
 42   Acetate   Acetate   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 43   Adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271 
 44   Adalimumab (40 mg)   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 45   Adalimumab (d2e7)   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
271 
 46   Adalimumab 40 mg eow or ew   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 47   Adalimumab and infliximab   Adalimumab, Infliximab   D02597, D02598   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 48   Adalimumab injection   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 49   Adalimumab prn   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 50   Adult human mesenchymal stem cells   Remestemcel-L   D09719   -   -   2件:
85,
96 
 51   Agri-king synbiotic (aksb)   -   -   -   -   1件:
96 
 52   Ain457   -   -   -   -   7件:
13,
37,
41,
46,
56,
96,
271 
 53   Albendazole   Albendazole   D00134   -   -   1件:
96 
 54   Albendazole (eskazole)   Albendazole   D00134   -   -   1件:
96 
 55   Alemtuzumab   Alemtuzumab   D02802   -   -   13件:
13,
15,
19,
20,
46,
51,
60,
63,
65,
85,
96,
164,
284 
 56   Alequel   -   -   -   -   1件:
96 
 57   Alfacalcidol   Alfacalcidol   D01518   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   6件:
41,
46,
49,
50,
96,
235 
 58   Alicaforsen   Alicaforsen   -   -   -   2件:
96,
97 
 59   Alicalm (polymeric liquid formula)   -   -   -   -   1件:
96 
 60   Allo-asc   -   -   -   -   1件:
96 
 61   Allo-asc-cd   -   -   -   -   1件:
96 
 62   Allogeneic bone marrow derived human mesenchymal stem cells (hmscs)   -   -   -   -   1件:
96 
 63   Allogeneic stem cell therapy   -   -   -   -   1件:
96 
 64   Allogenic eascs 5 million cells/ml suspension for injection cx601   -   -   -   -   1件:
96 
 65   Allogenic eascs 5 million cells/ml suspension for injection. cx601   -   -   -   -   1件:
96 
 66   Allopurinol   Allopurinol   D00224   1件: XDH   2件: Peroxisome, Purine metabolism   6件:
6,
46,
57,
66,
96,
97 
 67   Allopurinol sandoz 100 mg, tabletten   Allopurinol   D00224   1件: XDH   2件: Peroxisome, Purine metabolism   1件:
96 
 68   Allopurinol sodium   Allopurinol   D00224   1件: XDH   2件: Peroxisome, Purine metabolism   1件:
96 
 69   Alx-0600   -   -   -   -   1件:
96 
 70   Amg 139   -   -   -   -   1件:
96 
 71   Amg 181   -   -   -   -   2件:
96,
97 
 72   Amg 827   -   -   -   -   2件:
46,
96 
 73   Amg 827 210 mg   -   -   -   -   2件:
46,
96 
 74   Amg 827 350 mg   -   -   -   -   1件:
96 
 75   Amg 827 700 mg   -   -   -   -   1件:
96 
 76   Amgevita 40mg solution for injection   -   -   -   -   2件:
96,
97 
 77   Aminosalicylic acid   Aminosalicylic Acid   D00162   -   -   2件:
96,
97 
 78   Ammonium chloride   Ammonium chloride, Chloride ion   D01139   -   -   1件:
96 
 79   Amoxicillin   Amoxicillin   D00229, D02925, D07452   -   -   6件:
6,
46,
63,
96,
97,
222 
 80   An100226   -   -   -   -   2件:
13,
96 
 81   Andecaliximab   -   -   -   -   3件:
46,
96,
299 
 82   Andosan   -   -   -   -   2件:
96,
97 
 83   Anti tnf alfa.   -   -   -   -   1件:
96 
 84   Anti tnf humanized antibody fab fragment-peg conjugate   -   -   -   -   1件:
96 
 85   Anti tnf therapy including infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 86   Anti-cd3   Muromonab   D05092   3件: CD3D, CD3E, CD3G   3件: T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
96,
97 
 87   Anti-cd3 monoclonal antibody   Muromonab   D05092   3件: CD3D, CD3E, CD3G   3件: T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   2件:
96,
97 
 88   Anti-il-12   -   -   -   -   2件:
13,
96 
 89   Anti-interferon-gamma monoclonal antibody   -   -   -   -   1件:
96 
 90   Anti-madcam antibody   -   -   -   -   2件:
96,
97 
 91   Anti-tnf   -   -   -   -   3件:
46,
96,
271 
 92   Anti-tnf discontinuation: physiological saline solution   -   -   -   -   2件:
96,
97 
 93   Anti-tnf drug   -   -   -   -   2件:
96,
97 
 94   Anti-tnf therapy   -   -   -   -   3件:
46,
96,
97 
 95   Anti-tnf: infliximab (infusion)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 96   Anti-tnf:adalimumab (subcutaneus)   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 97   Apd334   -   -   -   -   4件:
93,
96,
97,
269 
 98   Apd371   -   -   -   -   1件:
96 
 99   Apixaban   Apixaban   D03213   1件: F10   1件: Complement and coagulation cascades   2件:
96,
97 
 100   Apixaban 2.5 milligram   Apixaban   D03213   1件: F10   1件: Complement and coagulation cascades   2件:
96,
97 
 101   Application of adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 102   Ast-120   -   -   -   -   2件:
96,
97 
 103   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 104   Autologous cd34-selected peripheral blood stem cells transplant   -   -   -   -   1件:
96 
 105   Autologous mesenchymal stromal cell   -   -   -   -   2件:
96,
298 
 106   Autologous ovalbumin-specific type 1 regulatory t lymphocytes expanded population   -   -   -   -   1件:
96 
 107   Autologous stem cell transplantation   -   -   -   -   2件:
56,
96 
 108   Azathioprin-ratiopharm 25mg filmtabletten   -   -   -   -   1件:
96 
 109   Azathioprin-ratiopharm 50 mg filmtabletten   -   -   -   -   1件:
96 
 110   Azathioprine   Azathioprine   D00238, D03033   -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162 
 111   Azathioprine (aza) or 6-mercaptopurine (6-mp)   Mercaptopurine, Azathioprine   D00161, D00238, D03033, D04931   1件: HPRT1   1件: Purine metabolism   2件:
96,
97 
 112   Azathioprine in case of endoscopic recurrence   Azathioprine   D00238, D03033   -   -   1件:
96 
 113   Azathioprine individualised dose   Azathioprine   D00238, D03033   -   -   1件:
96 
 114   Azathioprine or 6-mercaptopurine   Mercaptopurine, Azathioprine   D00161, D00238, D03033, D04931   1件: HPRT1   1件: Purine metabolism   2件:
96,
97 
 115   Azathioprine or adalimumab and infliximab   Adalimumab, Azathioprine, Infliximab   D00238, D02597, D02598, D03033   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 116   Azathioprine or mesalazine   Azathioprine, Mesalazine   D00238, D00377, D03033   -   -   1件:
96 
 117   Azathioprine or methotrexate   Azathioprine, Methotrexate   D00142, D00238, D02115, D03033   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   1件:
96 
 118   Azathioprine weight-based dose   Azathioprine   D00238, D03033   -   -   1件:
96 
 119   Azathioprine+enteral nutrition   Azathioprine   D00238, D03033   -   -   1件:
96 
 120   Azatioprina   Azathioprine   D00238, D03033   -   -   3件:
13,
96,
97 
 121   Azd9056   AZD9056   -   -   -   2件:
46,
96 
 122   Azithromycin   Azithromycin   D02134, D06390, D07486   -   -   6件:
13,
84,
85,
96,
228,
299 
 123   Azithromycin + metronidazole   Azithromycin, Metronidazole   D00409, D02134, D05016, D05017, D06390, D07486   -   -   1件:
96 
 124   B. theta   -   -   -   -   1件:
96 
 125   Bacteriophage preparation   -   -   -   -   1件:
96 
 126   Bacteriotherapy   -   -   -   -   2件:
96,
97 
 127   Bean   Bean   -   -   -   1件:
96 
 128   Beta carotene   Beta carotene   D03101   -   -   1件:
96 
 129   Beta carotene from dunaliella algae   Beta carotene   D03101   -   -   1件:
96 
 130   Betamethasone   Betamethasone   D00244, D00972, D01357, D01402, D01637, D02032, D02286   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   6件:
2,
46,
65,
90,
96,
235 
 131   Bfahf-2   -   -   -   -   1件:
96 
 132   Bi 655066   -   -   -   -   2件:
96,
271 
 133   Bi 655066 10 mg/ml   -   -   -   -   1件:
96 
 134   Bi 655066 90 mg/ml   -   -   -   -   2件:
96,
271 
 135   Bi 655130   -   -   -   -   3件:
37,
96,
97 
 136   Bi 695501   -   -   -   -   2件:
46,
96 
 137   Bibr 796 bs, 20 mg   -   -   -   -   1件:
96 
 138   Bibr 796 bs, 5 mg   -   -   -   -   1件:
96 
 139   Bifidobacterium infantis   Bifidobacterium longum infantis   -   -   -   2件:
96,
97 
 140   Bifidobacterium infantis 35624   Bifidobacterium longum infantis   -   -   -   2件:
96,
97 
 141   Biological samplings   -   -   -   -   1件:
96 
 142   Biosimilar   -   -   -   -   4件:
46,
96,
97,
271 
 143   Biosimilar infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
96,
97 
 144   Bli-1300 high dose   -   -   -   -   1件:
96 
 145   Bli-1300 low dose   -   -   -   -   1件:
96 
 146   Blood and stools samples   -   -   -   -   1件:
96 
 147   Blood sampling   -   -   -   -   4件:
13,
19,
51,
96 
 148   Bms-188667   bms-188667   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   6件:
46,
49,
65,
96,
97,
271 
 149   Bms-936557 (anti-ip-10 antibody)   -   -   -   -   1件:
96 
 150   Bms-945429   Clazakizumab   D10312   -   -   2件:
46,
96 
 151   Bms-986165   -   -   -   -   3件:
49,
96,
97 
 152   Bms986165   -   -   -   -   1件:
96 
 153   Bone marrow derived mesenchymal stem cells (mscs)   -   -   -   -   1件:
96 
 154   Boulardii   -   -   -   -   2件:
96,
97 
 155   Brazikumab   -   -   -   -   2件:
96,
97 
 156   Brazikumab high dose   -   -   -   -   1件:
96 
 157   Brazikumab low dose   -   -   -   -   1件:
96 
 158   Bt-11 1,000 mg   -   -   -   -   1件:
96 
 159   Bt-11 active   -   -   -   -   2件:
96,
97 
 160   Budenofalk   -   -   -   -   1件:
96 
 161   Budenofalk 3mg gastro-resistant capsules   -   -   -   -   1件:
96 
 162   Budenofalk 9mg gastro-resistant granules   -   -   -   -   1件:
96 
 163   Budesonide   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   9件:
66,
93,
94,
95,
96,
97,
98,
228,
299 
 164   Budesonide ( zentacort capsules 3mg )   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
96 
 165   Bupivacaine   Bupivacaine   D01450, D07552   1件: SCN1A   1件: Dopaminergic synapse   7件:
46,
53,
70,
96,
168,
226,
298 
 166   Bupivacaine/epinephrine/dexamethasone   Bupivacaine, Dexamethasone, Epinephrine   D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552   11件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A   8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   1件:
96 
 167   Bupropion   Bupropion   D00817, D07591, D07938   2件: SLC6A2, SLC6A3   2件: Dopaminergic synapse, Synaptic vesicle cycle   2件:
8,
96 
 168   C326, il-6 inhibitory avimer protein   -   -   -   -   1件:
96 
 169   Caffeine   Caffeine   D00528, D01453   9件: ADORA1, ADORA2A, PDE1B, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway   6件:
2,
6,
46,
78,
96,
97 
 170   Caffeine 100 mg   Caffeine   D00528, D01453   9件: ADORA1, ADORA2A, PDE1B, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
96 
 171   Calcitonin nasal spray (salmon)   -   -   -   -   2件:
96,
97 
 172   Calcitriol   Calcitriol   D00129   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   8件:
37,
46,
49,
66,
96,
158,
235,
326 
 173   Calcium   Calcium   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299 
 174   Calcium carbonate   Calcium, Carbonate ion   -   -   -   7件:
13,
19,
46,
75,
96,
235,
299 
 175   Cannabidiol   Cannabidiol   D10915   2件: CNR1, CNR2   1件: Neuroactive ligand-receptor interaction   13件:
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 176   Cannabis   Medical Cannabis   -   -   -   6件:
2,
6,
13,
90,
96,
97 
 177   Cannabis, medical   Medical Cannabis   -   -   -   5件:
2,
6,
13,
96,
97 
 178   Carbon   Activated charcoal   D03251   -   -   7件:
6,
46,
85,
86,
96,
97,
298 
 179   Carbonate   Carbonate ion   -   -   -   10件:
2,
13,
17,
19,
46,
75,
96,
127,
235,
299 
 180   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 181   Cc-5013   cc-5013   D04687   1件: TNF   6件: Apoptosis, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, TNF signaling pathway   2件:
28,
96 
 182   Ccx282-b   -   -   -   -   1件:
96 
 183   Cdp6038   -   -   -   -   2件:
46,
96 
 184   Cdp870   cdp870   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   3件:
46,
96,
271 
 185   Celebrex   Celecoxib   D00567   1件: PTGS2   1件: Arachidonic acid metabolism   3件:
46,
96,
271 
 186   Certican   Everolimus   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   2件:
96,
228 
 187   Certolizumab   -   -   -   -   3件:
46,
96,
271 
 188   Certolizumab pegol   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   6件:
37,
46,
96,
97,
226,
271 
 189   Certolizumab pegol (cdp870)   Certolizumab pegol, cdp870   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   1件:
96 
 190   Certolizumab pegol (czp)   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   3件:
46,
96,
271 
 191   Certolizumab pegol (rinn)   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   1件:
96 
 192   Certolizumab pegol 400 mg   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   1件:
96 
 193   Chadox2 hav   -   -   -   -   1件:
96 
 194   Chenodeoxycholic acid   Chenodeoxycholic acid   D00163   1件: NR1H4   1件: Bile secretion   4件:
20,
96,
234,
263 
 195   Chenodiol   Chenodeoxycholic acid   D00163   1件: NR1H4   1件: Bile secretion   1件:
96 
 196   Chenofalk   chenofalk   D00163   1件: NR1H4   1件: Bile secretion   1件:
96 
 197   Chloride   Chloride ion   -   -   -   17件:
6,
11,
13,
14,
34,
46,
51,
96,
97,
127,
168,
193,
227,
228,
288,
297,
299 
 198   Cholecalciferol   Cholecalciferol   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   9件:
13,
19,
34,
46,
49,
96,
97,
298,
299 
 199   Cholecalciferol 10,000 iu   Cholecalciferol   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   1件:
96 
 200   Cholecalciferol 400 iu   Cholecalciferol   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   1件:
96 
 201   Cholecalciferol concentrate   Cholecalciferol   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   1件:
96 
 202   Chondroitin sulfate   Chondroitin sulfate, Sulfate ion   D00080   -   -   2件:
96,
226 
 203   Cimzia   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   4件:
46,
96,
97,
271 
 204   Cimzia 200 mg solution for injection   Certolizumab pegol   D03441   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   2件:
46,
96 
 205   Ciprofloxacin   Ciprofloxacin   D00186, D02216   -   -   5件:
2,
60,
96,
97,
299 
 206   Ciprofloxacin hydrochloride   Ciprofloxacin   D00186, D02216   -   -   2件:
96,
299 
 207   Clarithromycin   Clarithromycin   D00276   -   -   8件:
6,
63,
84,
96,
97,
222,
228,
299 
 208   Clofarabine   Clofarabine   D03546   3件: POLA1, POLA2, RRM1   3件: DNA replication, Purine metabolism, Pyrimidine metabolism   9件:
19,
20,
40,
46,
49,
60,
96,
234,
326 
 209   Clofazimine   Clofazimine   D00278   -   -   1件:
96 
 210   Cnto 1275   cnto 1275   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
13,
96 
 211   Cnto1275   -   -   -   -   3件:
46,
84,
96 
 212   Cnto1959   -   -   -   -   1件:
96 
 213   Colecalciferol   Cholecalciferol   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   4件:
13,
46,
96,
228 
 214   Colesevelam   Colesevelam   D03582, D07743   -   -   2件:
96,
260 
 215   Colony-purified bacteroides thetaiotaomicron (b.theta)   -   -   -   -   1件:
96 
 216   Cortecosteroid   -   -   -   -   1件:
96 
 217   Corticosteroid   -   -   -   -   10件:
13,
42,
43,
44,
45,
66,
84,
96,
97,
222 
 218   Cosmofer   -   -   -   -   2件:
96,
97 
 219   Cosmofer 50mg/ml solution for infusion or injection   -   -   -   -   2件:
96,
97 
 220   Cp-461   -   -   -   -   1件:
96 
 221   Cp-690,550   -   -   -   -   4件:
46,
96,
97,
271 
 222   Cp-690,550-10   -   -   -   -   3件:
46,
96,
97 
 223   Cpsi-2364   -   -   -   -   1件:
96 
 224   Crohn's disease   -   -   -   -   1件:
96 
 225   Crohns disease exclusion diet + pen   -   -   -   -   1件:
96 
 226   Crown   -   -   -   -   1件:
96 
 227   Ct-p13   -   -   -   -   4件:
46,
96,
97,
271 
 228   Ct-p13 sc (infliximab)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 229   Ctla4ig   -   -   -   -   4件:
46,
49,
96,
271 
 230   Curcumin   Curcumin   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299 
 231   Cx601   -   -   -   -   1件:
96 
 232   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 233   D9421-c   -   -   -   -   1件:
96 
 234   D9421-c capsule 3 mg   -   -   -   -   1件:
96 
 235   D9421-c, 15mg   -   -   -   -   1件:
96 
 236   D9421-c, 9mg   -   -   -   -   1件:
96 
 237   Darvadstrocel   -   -   -   -   1件:
96 
 238   Db adalimumab 40 mg eow   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 239   Db adalimumab 40 mg ew   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 240   Decortin   decortin   D00068, D02798, D04855, D06542   -   -   5件:
46,
96,
97,
113,
145 
 241   Decortin 20 mg   decortin   D00068, D02798, D04855, D06542   -   -   1件:
96 
 242   Decortin 5 mg   decortin   D00068, D02798, D04855, D06542   -   -   1件:
96 
 243   Dehydroepiandrosterone   Prasterone   D08409   2件: ESR1, ESR2   1件: Estrogen signaling pathway   5件:
49,
53,
83,
96,
113 
 244   Dehydroepiandrosterone [dhea]   Prasterone   D08409   2件: ESR1, ESR2   1件: Estrogen signaling pathway   1件:
96 
 245   Dekristol 20.000 ie   -   -   -   -   1件:
96 
 246   Delayed release 6 mercaptopurine   Mercaptopurine, 6 mercaptopurine   D00161, D04931   1件: HPRT1   1件: Purine metabolism   1件:
96 
 247   Delayed release 6mp or calcitriol vs. purinethol   Mercaptopurine, Calcitriol   D00129, D00161, D04931   2件: HPRT1, VDR   3件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Purine metabolism   1件:
96 
 248   Denosumab   Denosumab   D03684   1件: TNFSF11   2件: Cytokine-cytokine receptor interaction, Osteoclast differentiation   7件:
46,
50,
93,
95,
96,
274,
299 
 249   Dexamethasone   Dexamethasone   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   20件:
13,
16,
28,
35,
46,
53,
63,
65,
70,
74,
75,
81,
83,
84,
90,
96,
97,
222,
296,
299 
 250   Dexamethasone sodium phosphate   Dexamethasone, Phosphate ion   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   2件:
65,
96 
 251   Dexamethasone sodium phosphate 250 mg/ 10 ml   Dexamethasone, Phosphate ion   D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
96 
 252   Dextran   Dextran   D00060   -   -   5件:
2,
62,
79,
96,
97 
 253   Dextromethorphan   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   9件:
2,
6,
8,
13,
46,
78,
96,
97,
156 
 254   Dextromethorphan 30 mg   Dextromethorphan   D00848, D03742, D03744   5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   2件: Glutamatergic synapse, Neuroactive ligand-receptor interaction   1件:
96 
 255   Dhea   Prasterone   D08409   2件: ESR1, ESR2   1件: Estrogen signaling pathway   3件:
49,
86,
96 
 256   Diet 1   -   -   -   -   1件:
96 
 257   Diet 2   -   -   -   -   1件:
96 
 258   Dietary therapy   -   -   -   -   1件:
96 
 259   Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon   Ammonium chloride, Chloride ion   D01139   -   -   1件:
96 
 260   Diflucan   Fluconazole   D00322, D01429   -   -   1件:
96 
 261   Dlx105   -   -   -   -   1件:
96 
 262   Doxycycline   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   15件:
13,
23,
28,
46,
84,
85,
89,
96,
97,
158,
162,
167,
227,
280,
299 
 263   Doxycycline hyclate   Doxycycline   D00307, D02129, D03903, D03904, D07876   -   -   3件:
23,
96,
227 
 264   E-device   -   -   -   -   3件:
46,
96,
271 
 265   E6011   -   -   -   -   3件:
46,
93,
96 
 266   E6011 10 mg/kg   -   -   -   -   1件:
96 
 267   E6011 15 mg/kg   -   -   -   -   1件:
96 
 268   E6011 2 mg/kg   -   -   -   -   1件:
96 
 269   E6011 5 mg/kg   -   -   -   -   1件:
96 
 270   Early immunosuppressants (azathioprine, methotrexate)   Azathioprine, Methotrexate   D00142, D00238, D02115, D03033   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   1件:
96 
 271   Eb8018 (first-in-class fimh blocker)   -   -   -   -   1件:
96 
 272   Efalizumab   Efalizumab   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   8件:
11,
13,
37,
46,
53,
61,
95,
96 
 273   Eicosapentaenoic acid   Icosapent   D08061   -   -   5件:
49,
96,
97,
296,
297 
 274   Entecavir   Entecavir   D04008, D07896   -   -   5件:
46,
56,
96,
97,
271 
 275   Enteral nutrition   -   -   -   -   1件:
96 
 276   Enteral nutrition.   -   -   -   -   1件:
96 
 277   Entocort   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
96 
 278   Entocort cr   Budesonide   D00246   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   1件:
96 
 279   Entocort® kapseln   -   -   -   -   1件:
96 
 280   Entyvio   Vedolizumab   D08083   2件: ITGA4, ITGB7   2件: Cell adhesion molecules (CAMs), ECM-receptor interaction   2件:
96,
97 
 281   Epanova   Omega-3-carboxylic acids   -   -   -   1件:
96 
 282   Epanova™ (omega-3 free fatty acids)   Omega-3 fatty acids   -   -   -   1件:
96 
 283   Epaxal berna (virosomal hepatitis a vaccine)   Hepatitis A Vaccine   -   -   -   2件:
96,
97 
 284   Epinephrine   Epinephrine   D00095, D00996, D02149   9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3   7件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway   2件:
46,
96 
 285   Erb-041   -   -   -   -   3件:
46,
96,
226 
 286   Ergocalciferol   Ergocalciferol   D00187   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   5件:
46,
84,
96,
97,
299 
 287   Ery-dex   -   -   -   -   1件:
96 
 288   Erythropoietin   Erythropoietin   D03231   1件: EPOR   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   8件:
2,
6,
13,
22,
47,
70,
95,
96 
 289   Eskazole   Albendazole   D00134   -   -   1件:
96 
 290   Etiprednol dicloacetate   Etiprednol dicloacetate   D04100   -   -   1件:
96 
 291   Etrolizumab   Etrolizumab   D09901   1件: ITGB7   1件: Intestinal immune network for IgA production   2件:
96,
97 
 292   Eu/1/99/116/003   -   -   -   -   1件:
96 
 293   Evaluation of biological predictive factors of clinical response to ustekinumab   Ustekinumab   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
96 
 294   Everolimus   Everolimus   D02714   1件: MTOR   4件: Breast cancer, ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   8件:
34,
67,
89,
96,
137,
157,
158,
277 
 295   Exclusive enteral nutrition   -   -   -   -   1件:
96 
 296   Exclusive enteral nutrition therapy   -   -   -   -   1件:
96 
 297   Expanded allogenic adipose-derived adult stem cells   -   -   -   -   1件:
96 
 298   Expanded autologous adipose-derived adult stem cells (eascs)   -   -   -   -   1件:
96 
 299   Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs)   -   -   -   -   1件:
96 
 300   Faecal microbiota transplantation   -   -   -   -   2件:
96,
97 
 301   Fe 999301   -   -   -   -   2件:
96,
97 
 302   Fecal microbial transplant   -   -   -   -   2件:
96,
97 
 303   Fecal microbial transplantation   -   -   -   -   2件:
96,
97 
 304   Fecal microbiota transplant   -   -   -   -   2件:
96,
97 
 305   Fecal microbiota transplant (fmt)   -   -   -   -   1件:
96 
 306   Fecal microbiota transplantation   -   -   -   -   5件:
2,
66,
94,
96,
97 
 307   Fecal microbiota transplantation (fmt)   -   -   -   -   2件:
96,
97 
 308   Ferric carboxy maltose   Maltose   D00044   -   -   1件:
96 
 309   Ferric carboxymaltose   Ferric carboxymaltose   D08920   -   -   4件:
86,
96,
97,
299 
 310   Ferric maltol   -   -   -   -   1件:
96 
 311   Ferrous sulphate   -   -   -   -   2件:
96,
97 
 312   Ffp104   -   -   -   -   2件:
93,
96 
 313   Filgotinib   Filgotinib   D10871   1件: JAK1   3件: JAK-STAT signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   6件:
46,
53,
96,
97,
222,
271 
 314   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 315   Fish oil   Fish oil   -   -   -   7件:
13,
46,
49,
66,
96,
260,
299 
 316   Fitc-adalimumab   Adalimumab   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 317   Flagyl   Metronidazole   D00409, D05016, D05017   -   -   2件:
96,
97 
 318   Fluconazole   Fluconazole   D00322, D01429   -   -   1件:
96 
 319   Fludarabine   Fludarabine   D01907, D07966   1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 320   Fludarabine phosphate   Fludarabine, Phosphate ion   D01907, D07966   1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   11件:
28,
36,
49,
51,
60,
62,
65,
96,
283,
284,
285 
 321   Fluorine f 18   Fluorine F 18   D05860   -   -   4件:
40,
46,
49,
96 
 322   Folatescan (technetium tc 99mec20)   -   -   -   -   4件:
13,
46,
49,
96 
 323   Fosfomycin   Fosfomycin   D00925, D02187, D02188, D04253   -   -   2件:
96,
97 
 324   G-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   12件:
6,
13,
16,
49,
51,
60,
65,
85,
96,
284,
285,
331 
 325   G321605   -   -   -   -   3件:
85,
96,
97 
 326   Ged-0301   -   -   -   -   2件:
96,
97 
 327   Glatiramer   Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   1件: Antigen processing and presentation   4件:
2,
13,
96,
156 
 328   Glatiramer acetate   Acetate, Glatiramer   D04318   20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G   1件: Antigen processing and presentation   3件:
13,
96,
156 
 329   Glpg0634   -   -   -   -   3件:
46,
96,
271 
 330   Glpg1205   GLPG1205   -   -   -   3件:
85,
96,
97 
 331   Glutamine   L-Glutamine   D00015   -   -   6件:
87,
96,
97,
113,
245,
299 
 332   Golimumab   Golimumab   D04358   1件: TNF   9件: Adipocytokine signaling pathway, Apoptosis, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   5件:
46,
84,
96,
97,
271 
 333   Green tea   Green tea leaf   D06903   -   -   5件:
6,
17,
28,
46,
96 
 334   Growth hormone   Somatotropin   D02691   1件: GHR   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction   11件:
2,
13,
19,
46,
78,
96,
191,
193,
195,
265,
299 
 335   Gs-6034   -   -   -   -   3件:
46,
96,
97 
 336   Gsk1070806   -   -   -   -   2件:
56,
96 
 337   Gsk1605786   -   -   -   -   2件:
96,
97 
 338   Gsk1605786 500 mg   -   -   -   -   1件:
96 
 339   Gsk1605786 capsule   -   -   -   -   1件:
96 
 340   Gsk1605786 chemocentryx: formulation a   -   -   -   -   1件:
96 
 341   Gsk1605786 gsk direct-fill: formulation c   -   -   -   -   1件:
96 
 342   Gsk1605786 gsk modified-process: formulation d   -   -   -   -   1件:
96 
 343   Gsk1605786 gsk tablet: formulation e   -   -   -   -   1件:
96 
 344   Gsk1605786 gsk: formulation b   -   -   -   -   1件:
96 
 345   Gsk1605786a   -   -   -   -   2件:
96,
97 
 346   Gsk2330811   -   -   -   -   2件:
51,
96 
 347   Guselkumab   Guselkumab   D10438   1件: IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   3件:
37,
96,
97 
 348   Hematopoietic stem cell transplantation   -   -   -   -   12件:
11,
13,
14,
19,
20,
35,
46,
49,
51,
96,
234,
285 
 349   Hepatitis a vaccine   Hepatitis A Vaccine   -   -   -   3件:
46,
96,
97 
 350   Herpes zoster vaccine   -   -   -   -   3件:
46,
96,
271 
 351   Hextend   Hydroxyethyl Starch   D03335   -   -   2件:
96,
97 
 352   High oligosaccharide group   -   -   -   -   1件:
96 
 353   High-dose cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   1件:
96 
 354   Hmpl004   -   -   -   -   1件:
96 
 355   Hmpl004-6599   -   -   -   -   2件:
96,
97 
 356   Hum291   -   -   -   -   2件:
96,
97 
 357   Human anti-il-12 antibody   -   -   -   -   1件:
96 
 358   Human insulin   Insulin Human   D00085, D03230   1件: INSR   2件: Insulin signaling pathway, Type II diabetes mellitus   2件:
96,
156 
 359   Human monoclonal antibody (cnto 1275) to interleukin 12p-40   cnto 1275   D09214   3件: IL12A, IL12B, IL23A   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   1件:
96 
 360   Human placenta-derived cells pda001 intravenous infusion   -   -   -   -   1件:
96 
 361   Human plasma for fractionation   -   -   -   -   1件:
96 
 362   Humira   Isopropyl alcohol   D00137   -   -   6件:
46,
84,
96,
97,
269,
271 
 363   Humira (adalimumab)   Adalimumab, Isopropyl alcohol   D00137, D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
46,
96 
 364   Humira 40 mg solution for injection in pre-filled syringe   Isopropyl alcohol   D00137   -   -   3件:
46,
96,
97 
 365   Humira 40mg solution for injection   -   -   -   -   2件:
96,
97 
 366   Humira pre-filled pen   Isopropyl alcohol   D00137   -   -   1件:
96 
 367   Humira®   -   -   -   -   4件:
46,
96,
97,
271 
 368   Hydroxide   Hydroxide ion   -   -   -   4件:
46,
96,
97,
284 
 369   Hydroxychloroquine   Hydroxychloroquine   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299 
 370   Hydroxychloroquine sulphate   Hydroxychloroquine   D08050   -   -   1件:
96 
 371   Il-2   Human interleukin-2, il-2   -   -   -   5件:
2,
46,
49,
56,
96 
 372   Immune ablation and hematopoietic stem cell support   -   -   -   -   1件:
96 
 373   Immunonutrition   -   -   -   -   1件:
96 
 374   Immunosuppressor/tnfalpha   -   -   -   -   1件:
96 
 375   Impact   Topramezone   -   -   -   7件:
6,
13,
46,
50,
96,
97,
299 
 376   Imuran   Azathioprine   D00238, D03033   -   -   2件:
96,
97 
 377   Imurel   -   -   -   -   2件:
96,
97 
 378   Increlex   Mecasermin   D03297, D04870   2件: GHR, IGF1R   1件: PI3K-Akt signaling pathway   3件:
65,
78,
96 
 379   Increlex 10mg/ml solution for injection   Mecasermin   D03297, D04870   2件: GHR, IGF1R   1件: PI3K-Akt signaling pathway   1件:
96 
 380   Inflectra   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 381   Infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   22件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
95,
96,
97,
98,
162,
164,
269,
271 
 382   Infliximab (ifx alone)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 383   Infliximab (remicade)   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
96,
271 
 384   Infliximab (remicade): 100 mg of lyophilized infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 385   Infliximab 10 mg/kg   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
96,
97 
 386   Infliximab 20 mg/kg   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 387   Infliximab 5 mg/kg   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 388   Infliximab 5 mg/kg body weight infused over 2 hours   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 389   Infliximab 5 mg/kg every 6 weeks   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 390   Infliximab 7 mg/kg every 8 weeks   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 391   Infliximab [infliximab biosimilar 3]   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   4件:
37,
46,
96,
97 
 392   Infliximab and adalimumab   Adalimumab, Infliximab   D02597, D02598   1件: TNF   10件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 393   Infliximab and azathioprine combination at week 0   Azathioprine, Infliximab   D00238, D02598, D03033   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 394   Infliximab and azathioprine combination at week 14   Azathioprine, Infliximab   D00238, D02598, D03033   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 395   Infliximab infusion   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 396   Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab   Adalimumab, Golimumab, Infliximab, Ustekinumab, Vedolizumab   D02597, D02598, D04358, D08083, D09214   6件: IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF   14件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cell adhesion molecules (CAMs), Cytokine-cytokine receptor interaction, ECM-receptor interaction, Fc epsilon RI signaling pathway, Inflammatory bowel disease (IBD), JAK-STAT signaling pathway, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   2件:
96,
97 
 397   Infliximab with azathioprine (iifx + aza)   Azathioprine, Infliximab   D00238, D02598, D03033   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 398   Infliximab+azathioprine   Azathioprine, Infliximab   D00238, D02598, D03033   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 399   Infliximab, adalimumab, certolizumab pegol   Adalimumab, Certolizumab pegol, Infliximab   D02597, D02598, D03441   1件: TNF   11件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway, Toll-like receptor signaling pathway   2件:
96,
97 
 400   Infliximab, azathioprine   Azathioprine, Infliximab   D00238, D02598, D03033   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 401   Infliximab-biosimilar   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 402   Infliximab-innovator   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   1件:
96 
 403   Injection of iron   Docusate   D00305   -   -   1件:
96 
 404   Innovator infliximab   Infliximab   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   3件:
46,
96,
97 
 405   Inositol   Inositol   D08079   -   -   2件:
96,
97 
 406   Interferon alfa   Interferon alfa   D03305   2件: IFNAR1, IFNAR2   8件: Cytokine-cytokine receptor interaction, Hepatitis B, Hepatitis C, JAK-STAT signaling pathway, Measles, Natural killer cell mediated cytotoxicity, Pathways in cancer, Toll-like receptor signaling pathway   5件:
25,
26,
28,
56,
96 
 407   Interferon beta   Human interferon beta, interferon beta   -   -   -   6件:
13,
14,
20,
26,
96,
97 
 408   Interferon beta-1a   Human interferon beta, Interferon beta-1a, interferon beta   D04554   2件: IFNAR1, IFNAR2   4件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Toll-like receptor signaling pathway   5件:
13,
14,
26,
96,
97 
 409   Interleukin 2   Human interleukin-2, interleukin 2   -   -   -   9件:
46,
49,
51,
56,
63,
95,
96,
97,
271 
 410   Interleukin-11   Oprelvekin   D05266   1件: IL11RA   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   2件:
96,
288 
 411   Intralipid   Soybean oil   D04962   -   -   1件:
96 
 412   Intralipid 10%   -   -   -   -   1件:
96 
 413   Inulin   Inulin   D00171   -   -   2件:
96,
299 
 414   Invita d3   -   -   -   -   1件:
96 
 415   Iron   Docusate   D00305   -   -   7件:
13,
62,
86,
96,
97,
254,
284 
 416   Iron sucrose   Docusate, Iron saccharate, Sucrose   D00025, D00305   -   -   3件:
62,
96,
97 
 417   Iron sulphate   Docusate   D00305   -   -   2件:
96,
97 
 418   Iron sulphate 200mg coated tablets   Docusate   D00305   -   -   2件:
96,
97 
 419   Iron supplement 300-600 mg/day   Docusate   D00305   -   -   2件:
96,
97 
 420